Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Justin Allen, MD

Articles by Justin Allen, MD

depression

Clinical Features Associated With Response to Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression

ByJustin Allen, MD,Lalangi Marasinghe, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

March 19th 2025

Ketamine or ECT? A new study reveals which works best for severe depression—depending on the patient and setting.

How efficacious is brexpiprazole as a treatment for agitation associated with Alzheimer disease?

Exploring the Role of Brexpiprazole in Alzheimer Dementia Agitation

ByJustin Allen, MD,Albert Dickan, MD,Jesse Woo, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

January 16th 2024

How efficacious is brexpiprazole as a treatment for agitation associated with Alzheimer disease?

Latest Updated Articles

Exploring the Role of Brexpiprazole in Alzheimer Dementia Agitation
Published: January 16th 2024 | Updated:
Clinical Features Associated With Response to Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression
Published: March 19th 2025 | Updated:

Trending on Psychiatric Times

Preliminary Report on Dangers of AI Chatbots

Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases

The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law

6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia

Suicide: Can Emergency Departments Assist in its Prevention?

© 2025 MJH Life Sciences^®

All rights reserved.